Health Industry Issues “Urgent Call” for Massive Public Spending Boost in Union Budget 2026-27

NEW DELHI, Jan 19, 2026 — As the countdown to the Union Budget 2026-27 begins, India’s healthcare leadership has issued a collective and urgent appeal to the central government: move beyond incremental increases and commit to a transformative leap in public health spending.

Industry stalwarts, led by the Association of Healthcare Providers – India (AHPI) and the Indian Pharmaceutical Alliance (IPA), are urging Finance Minister Nirmala Sitharaman to finally bridge the gap to the 2.5% of GDP spending target mandated by the National Health Policy 2017—a milestone that remains elusive despite a decade of promises.

The GDP Gap: A Growing Fiscal Risk

For years, India’s public health expenditure has hovered below the 2% mark. While the Union Budget 2025-26 allocated approximately ₹95,958 crore—a marginal increase from the previous year—experts argue this is no longer sufficient to sustain a nation of 1.4 billion people facing a “dual disease burden.”

“To secure a healthier future for India, it is imperative to invest in robust health systems today,” said Dr. Girdhar Gyani, Director General of AHPI. “We urge the government to substantially enhance funding, laying the foundation for world-class and inclusive care. Expanding infrastructure and strengthening the workforce in Tier 2 and Tier 3 cities are critical to meet the nation’s evolving needs.”

The “Dual Burden” Challenge

India is currently battling two fronts simultaneously:

1. Communicable Diseases: Ongoing battles with tuberculosis (affecting ~2.8 million annually) and vector-borne diseases like dengue and malaria.

2. Non-Communicable Diseases (NCDs): A “silent pandemic” of diabetes, hypertension, and cardiovascular diseases that now account for over 63% of all deaths in the country.

Industry leaders highlight that NCDs are not just a health crisis but an economic one, with projections suggesting India could lose trillions in productivity by 2030 if preventive care is not prioritized.

Strategic Demands: Innovation, Tax Reform, and Access

The wishlist for Budget 2026-27 extends beyond just the total outlay. Leaders are calling for structural reforms to make the healthcare ecosystem more resilient and affordable.

1. The GST Paradox

A significant hurdle for hospitals and manufacturers remains the complex Goods and Services Tax (GST) structure. Currently, many lifesaving medical devices and raw materials face an “inverted duty structure,” where inputs are taxed higher than the final product, driving up costs for patients.

Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance, emphasized the need for “rationalizing the GST structure and reintroducing concessional tax regimes for new facilities” to support manufacturing competitiveness.

2. Digital Health and “NCD Resilience”

Ameera Shah, President of NATHEALTH, proposed the creation of an NCD Resilience Fund. This would be funded by earmarking a portion of the existing health cess to specifically target early screening and long-term management of chronic conditions.

“The budget must accelerate investments in technology-driven care,” added Dr. Sunil K. Khetarpal, Deputy Director General of AHPI. This includes scaling the Ayushman Bharat Digital Mission (ABDM), which has already registered over 830 million citizens, to ensure seamless data sharing and telemedicine access in rural areas.

Practical Implications: What This Means for You

For the average citizen, the outcome of the February budget will directly impact two things: affordability and proximity.

• Lower Out-of-Pocket Expenses: Currently, nearly 48% of healthcare costs in India are paid directly by households. Increased public spending is expected to reduce this burden by strengthening the Ayushman Bharat insurance scheme and providing free essential medicines at government centers.

• Quality Care Near Home: The push for Tier 2 and Tier 3 city development means patients may no longer need to travel to metros like Delhi or Mumbai for specialized surgeries or cancer treatments.

Potential Roadblocks and Counterarguments

While the industry’s demands are clear, economists warn of the fiscal tightrope the government must walk. Balancing a massive healthcare hike against infrastructure needs in defense and energy is a perennial challenge.

Furthermore, some public health advocates argue that simply increasing the “outlay” isn’t enough; the focus must be on “outcome.” There are concerns regarding the absorption capacity of state health systems, where funds often remain unspent due to administrative bottlenecks or a lack of trained medical personnel.

Looking Ahead

As Jan 20, 2026, marks the final weeks of budget consultations, the message from the medical community is unanimous: Healthcare is not a cost—it is an investment in India’s “human capital.” Whether the government will meet the 2.5% GDP gold standard remains the most anticipated question for the sector.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

https://www.indiatribune.com/public/union-budget-2026-27-industry-leaders-urge-govt-to-boost-healthcare-delivery-investment#:~:text=The%20association%20stressed%20that%20Budget,in%20robust%20health%20systems%20today.